Due to its elevation in the CSF of AD and also in AD patients at a stadium of mild cognitive impairment (AD-MCI), VILIP-1 has been shown to be of diagnostic and prognostic value [19–22]. The gene discussed is VSNL1; the disease is Cognitive impairment.